North America Unit Dose Manufacturing Market is expected to expand at a CAGR of 16.9% from 2021 to 2028
North America Unit Dose Manufacturing Industry Overview The North America unit dose manufacturing market size was estimated at USD 6.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.9% from 2021 to 2028. The market is majorly driven by various advantages associated with unit doses such as reduction in medication errors. They also play a vital role in improving drug control and drug use monitoring. Moreover, unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules. Gather more insights about the market drivers, restrains and growth of the North America Unit Dose Manufacturing Market The COVID-19 pandemic had a significant influence on the healthcare market, particularly the pharmaceutical industry, with significant implications on the short and long-term prospects, requiring effective planning to limit socioeconomic burden. Demand shi...